Commentary: data monitoring confidentiality and FDA transparency

Clin Trials. 2015 Feb;12(1):12-4. doi: 10.1177/1740774514561047. Epub 2014 Dec 18.

Author

Alex John London¹

Affiliation

¹ Center for Ethics and Policy, Department of Philosophy, Carnegie Mellon University, Pittsburgh, PA, USA ajlondon@andrew.cmu.edu.

PMID: 25525073
DOI: 10.1177/1740774514561047

No abstract available

Publication types

Comment

MeSH terms

Clinical Trials Data Monitoring Committees / organization & administration*
Clinical Trials as Topic / methods*
Data Anonymization / standards*
Female
Humans
Male